Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Broz

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Burns : Journal of the International Society for Burn Injuries|March 17, 2004
Initial optimal continuous distension pressure in prone HFOV in a paediatric burn: case reportJ Pachl, L Broz, J Kripner, et al.
Cancer Cell|July 19, 2016
Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in MelanomaEdward W Roberts, Miranda L Broz, Mikhail Binnewies, et al.
Cancer Research|January 1, 2016
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and MetastasisLaura M Jones, Miranda L Broz, Jill J Ranger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2020
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation TherapyTiffany C Blair, Shelly Bambina, Alejandro F Alice, et al.
International Journal of Cancer|August 6, 2022
A multi-omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti-PD1 response in solid tumorsNamit Kumar, Simon Papillon-Cavanagh, Hao Tang, et al.
Cancer Cell|December 3, 2014
Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Cancer Cell|September 13, 2017
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Nature Medicine|June 27, 2018
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironmentsKevin C Barry, Joy Hsu, Miranda L Broz, et al.
Journal for Immunotherapy of Cancer|March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomasE Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Burns : Journal of the International Society for Burn Injuries|March 17, 2004
Initial optimal continuous distension pressure in prone HFOV in a paediatric burn: case reportJ Pachl, L Broz, J Kripner, et al.
Cancer Cell|July 19, 2016
Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in MelanomaEdward W Roberts, Miranda L Broz, Mikhail Binnewies, et al.
Cancer Research|January 1, 2016
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and MetastasisLaura M Jones, Miranda L Broz, Jill J Ranger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2020
Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation TherapyTiffany C Blair, Shelly Bambina, Alejandro F Alice, et al.
International Journal of Cancer|August 6, 2022
A multi-omic single cell sequencing approach to develop a CD8 T cell specific gene signature for anti-PD1 response in solid tumorsNamit Kumar, Simon Papillon-Cavanagh, Hao Tang, et al.
Cancer Cell|December 3, 2014
Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Cancer Cell|September 13, 2017
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell ImmunityMiranda L Broz, Mikhail Binnewies, Bijan Boldajipour, et al.
Nature Medicine|June 27, 2018
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironmentsKevin C Barry, Joy Hsu, Miranda L Broz, et al.
Journal for Immunotherapy of Cancer|March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomasE Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
Pageof 5